ABIVAX Société Anonyme (EPA:ABVX)
France · Delayed Price · Currency is EUR 77.15
-0.50 (-0.64%)
Nov 6, 2026, 5:36 PM CET
ABIVAX Société Anonyme Market Cap
ABIVAX Société Anonyme has a market cap or net worth of €6.73 billion as of November 6, 2026. It is the 2,625th most valuable company in the world and the 53rd biggest in France. Its market cap has increased by 4.58% in one year.
Market Cap
6.73B
Enterprise Value
6.32B
Revenue
4.67M
Global Rank
Country Rank
#53 France
PE Ratio
n/a
ChartMarket Cap Chart
Since June 26, 2015, ABIVAX Société Anonyme's market cap has increased from 202.12M to 6.73B, an increase of 3,227.54%. That is a compound annual growth rate of 36.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 6.73B | -28.23% |
| Dec 31, 2025 | 9.37B | 2,088.64% |
| Dec 31, 2024 | 428.15M | -30.40% |
| Dec 29, 2023 | 615.18M | 493.46% |
| Dec 30, 2022 | 103.66M | -77.81% |
| Dec 31, 2021 | 467.16M | -1.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.37B |
| MedinCell | 1.02B |
| Inventiva | 803.35M |
| DBV Technologies | 564.00M |
| Genfit | 530.33M |
| Valneva SE | 474.50M |
| Valerio Therapeutics Société anonyme | 234.74M |
| Transgene | 204.86M |